Rebus Biosystems: Funding, Investors & Team (Sep 2026)
Our mission at Rebus Biosystems is spatial omics without compromise. Get direct access to biological molecular resolution at the subcellular level in and across large tissue sections. You can concentrate on the targets that are most important to your research thanks to customizable assays. Early 2021 will see the release of a fully automated, integrated instrument for your lab. Access is now offered as part of our Spatial Omics as a Service offering.
Rebus Biosystems has raised $17.8M across 1 funding round on record, the most recent an undisclosed round of $17.8M announced in Nov 2022.
That round is above the $3.0M median round size for Biotechnology Research companies tracked on FundedIQ over the last two years.
Rebus Biosystems Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Rebus Biosystems Funding Rounds
Rebus Biosystems Founders and Leadership Team
No contact details are on record for this team yet.
Rebus Biosystems Funding Compared to Other Biotechnology Research Startups
Rebus Biosystems' latest round of $17.8M is above the median round in Biotechnology Research. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Rebus Biosystems in Biotechnology Research and Santa Clara
Companies Similar to Rebus Biosystems
FibroBiologics is a regenerative medicine firm situated in Houston, Texas that is working on an inventive…
FoamLab specializes in high-performance, bio-based foams made from bacterial nanocellulose and develops a new…
Intrinsic Foundries is pioneering carbon capture and utilization technology that converts industrial waste…
Auxilium Biotechnologies specializes in developing technology for repairing peripheral nerves.
Expedition Medicine's industry-leading chemoproteomics data generating engine learns the rules of molecular…
Avidicure is leading the way in developing a new type of antibody treatment called "AVC-Boosters", which have…
Orange Grove Bio (OGB) is a platform that specializes in investing and developing preclinical drugs, with the…
The Verschuren Centre assists in the advancement of sustainable technologies for cleantech companies and…
A new class of programmable polymer nanoparticles is being developed by Nanite, a next-generation non-viral…
a nonprofit organisation dedicated to reducing greenhouse gas emissions by genetically increasing CO2…
Love Lifesciences is creating a line of injection safety tools that will enhance patient comfort when…
Empatica is a startup that specializes in emotional computing and human data analytics. We create…
Rebus Biosystems Funding FAQs
What does Rebus Biosystems do?
Our mission at Rebus Biosystems is spatial omics without compromise. Get direct access to biological molecular resolution at the subcellular level in and across large tissue sections. You can concentrate on the targets that are most important to your research thanks to customizable assays. Early 2021 will see the release of a fully automated, integrated instrument for your lab. Access is now offered as part of our Spatial Omics as a Service offering.
How much funding has Rebus Biosystems raised?
Rebus Biosystems has raised $17.8M across 1 round on record. The most recent is an undisclosed round of $17.8M announced in Nov 2022.
When did Rebus Biosystems last raise funding?
Rebus Biosystems' most recent funding round on record is an undisclosed round of $17.8M, announced in Nov 2022.
Who founded Rebus Biosystems?
FundedIQ lists Josh Ryu (Founder) at Rebus Biosystems.
Where is Rebus Biosystems headquartered?
Rebus Biosystems is based in Santa Clara, California, United States.
How many employees does Rebus Biosystems have?
Rebus Biosystems is in the 11-50 employee band.
How does Rebus Biosystems' funding compare to other Biotechnology Research startups?
Rebus Biosystems' latest round of $17.8M is above the $3.0M median round size for Biotechnology Research companies on FundedIQ across 24 tracked companies over the last two years.
About FundedIQ's Rebus Biosystems Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rebus Biosystems is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.